Crossmark

Podcast Synopsis of Updates to the European Renal Best Practice and UK Kidney Association Guidelines for Treatment of Anaemia in Chronic Kidney Disease

Crossref DOI link: https://doi.org/10.1007/s12325-025-03366-6

Published Online: 2025-09-23

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cozzolino, Mario https://orcid.org/0000-0002-8494-6252
Stoumpos, Sokratis

Bhandari, Sunil
Funding

Funding for this research was provided by:

Lumanity Communications UK
License Information

Text and Data Mining valid from 2025-09-23

Version of Record valid from 2025-09-23
More Information

Article History

Received: 29 April 2025

Accepted: 1 September 2025

First Online: 23 September 2025

Declarations

:

: Mario Cozzolino has no competing interests to declare. Sokratis Stoumpos has received honoraria for lectures from AstraZeneca, Astellas Pharma Inc., and CSL Vifor. Sunil Bhandari has received consulting fees from Astellas Pharma Inc., AstraZeneca, and MEDICE and honoraria for lectures from Astellas Pharma Inc., AstraZeneca, Bayer, Lilly/Boehringer Ingelheim, MEDICE, and CSL Vifor.

: This podcast article is based on previously published guidelines and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below